BioScience Health Innovations, Inc. 8-K

What Happened
BioScience Health Innovations, Inc. (filed 8-K on April 2, 2026) announced that director Justin Earl has resigned from the company’s Board of Directors effective immediately. The company stated the resignation was not due to any disagreement with the company’s operations, policies, or practices. On April 1, 2026, the Board appointed Daniel (Dan) Schmidt to fill the vacancy; Mr. Schmidt has served as the company’s Chief Technology Officer since inception.

Key Details

• Filing: Form 8-K filed April 2, 2026 (Accession: 0001185185-26-001231).
• Resignation: Justin Earl resigned from the Board effective immediately; not due to any disagreement with the Company.
• Appointment: Daniel Schmidt appointed to the Board effective April 1, 2026 to fill the vacancy.
• Background: Mr. Schmidt has been CTO since the company’s inception and has ~26 years of experience in therapeutic medical devices and treatments (RF, stem cells, laser, ultrasound, non-surgical skin tightening and fat reduction).

Why It Matters
This is a board-level leadership change that maintains continuity: the Board filled the vacancy immediately with an internal executive (the CTO). For investors, the filing signals no reported governance dispute (resignation “not the result of any disagreement”) and preserves institutional technical leadership on the Board, which may matter for oversight of product and technology strategy.